Primary and Secondary Signaling Pathways in Early Preconditioning That Converge on the Mitochondria to Produce Cardioprotection

Circulation Research

Volumn 94, Issue 1, 2004, Pages 7-16

  Murphy, Elizabeth ^a,b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Box 12233 ^*  (United States)

Author keywords

Apoptosis; Cardioprotection; Mitochondria; Preconditioning; Signaling pathways

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; G PROTEIN COUPLED RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; POTASSIUM CHANNEL; PROTEIN BCL 2; PROTEIN KINASE C;

APOPTOSIS; CELL DEATH; ENZYME ACTIVATION; HEART MITOCHONDRION; HEART PROTECTION; HUMAN; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; SIGNAL TRANSDUCTION;

EID: 0346059584     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000108082.76667.F4     Document Type: Review

References (120)

1. 1 adenosine receptors in rabbit heart. Circulation. 1991;84:350-356.
2. Bell SP, Sack MN, Patel A, Opie LH, Yellon DM. δ Opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol. 2000;36:2296-2302.
3. + channels: possible mechanism of cardioprotection. Circ Res. 1997;81:1072-1082.
4. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 1995;77:611-621.
5. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994;266: H1145-H1152.
6. Murphy E, Cross HR, Steenbergen C. Sodium regulation during ischemia versus reperfusion and its role in injury. Circ Res. 1999;84:1469-1470.
7. Johassen A, Sacks M, Mjos O, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001;89:1191-1198.
8. Inagaki K, Chen L, Ikeno F, Lee F, Imahashi K, Bouley D, Rezaee M, Yock P, Murphy E, Mochly-Rosen D. Inhibition of δ protein kinase C protects against reperfusion injury of the ischemic heart. Circulation. 2003;108:2304-2307.
9. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic post-conditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol. 2003;285:H579-H588.
10. Xu Z, Jiao Z, Cohen MV, Downey JM. Protection from AMP 579 can be added to that from either cariporide or ischemic preconditioning in ischemic rabbit heart. J Cardiovasc Pharmacol. 2002;40:510-518.
11. Li Q, Guo Y, Xuan Y-T, Lownestein CJ, Stevenson SC, Prabhu SD, Wu W-J, Zhu Y, Bolli R. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism. Circ Res. 2003;92:741-748.
12. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, Griese DP, Dell'Acqua G, Mann MJ, Oyama J, Yet SF, Layne MD, Perrella MA, Dzau VJ. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation. 2002;105:602-607.
13. Hale SL, Kloner RA. Myocardial hypothermia: a potential therapeutic technique for acute regional myocardial ischemia. J Cardiovasc Electrophysiol. 1999;10:405-413.
14. Yaoita H, Ogawa K, Machara K, Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 1998;97:276-281.
15. Murphy E, Perlman M, London RE, Steenbergen C. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res. 1991;68:1250-1258.
16. Matsui T, Li L, del Monte F, Fakui Y, Franke T, Haijar R, Rosenzeig A. Adenovirus gene transfer of activated phosphatidylinositol-3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation. 1999;100:2373-2379.
17. Baines CP, Song CX, Zheng YT, Wang GW, Zhang J, Wang OL, Guo Y, Bolli R, Cardwell EM, Ping P. Protein kinase CE interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res. 2003;92:873-880.
18. Thornton JD, Liu GS, Downey JM. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for a G-protein mechanism. J Mol Cell Cardiol. 1993;25:311-320.
19. Fryer RM, Hsu AK, Gross GJ. ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol. 2001;96:136-142.
20. 1 receptor triggered) preconditioning: is eNOS masquerading as iNOS? Cardiovasc Res. 2002;53:405-413.
21. i proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc Res. 2002;55:544-552.
22. Krieg T, Qin Q, McIntosh EC, Cohen MV, Downey JM. ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases. Am J Physiol Heart Circ Physiol. 2002;283: H2322-H2330.
23. Naga Prasad SV, Barak LS, Rapacciuolo A, Caron MG, Rockman HA. Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by β-adrenergic receptor kinase 1: a role in receptor sequestration. J Biol Chem. 2001;276:18953-18959.
24. Tong H, Chen W, Steenbergen C, Murphy E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res. 2000;87:309-315.
25. Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3β during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res. 2002;90:377-379.
26. Kis A, Yellon DM, Baxter GF. Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. J Mol Cell Cardiol. 2003;35:1063-1071.
27. Qin Q, Downey JM, Cohen MV. Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase. Am J Physiol Heart Circ Physiol. 2003;284:H727-H734.
28. Schultz JE, Hsu AK, Barbieri JT, Li PL, Gross GJ. Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am J Physiol. 1998;275:H495-H500.
29. Liu Y, Downey JM. Preconditioning against infarction in the rat heart does not involve a pertussis toxin sensitive G protein. Cardiovasc Res. 1993;27:608-611.
30. Pierce KL, Luttrell LM, Lefkowitz RJ. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene. 2001;20:1532-1539.
31. Mocanu MM, Bell RM, Yellon DM. PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol. 2002;34:661-668.
32. Krieg T, Landsberger M, Alexeyev MF, Felix SB, Cohen MV, Downey JM. Activation of Akt is essential for acetylcholine to trigger generation of oxygen free radicals. Cardiovasc Res. 2003;58:196-202.
33. ATP channels in the isolated rabbit heart. Basic Res Cardiol. 1999;94:188-198.
34. Harada H, Anderson J, Mann M, Terada N, Korsmeyer S. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci U S A. 2001;98:9666-9670.
35. Yamashita K, Kajstura J, Discher D, Wasselauf B, Bishopric N, Anversa P, Webster K. Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor. Circ Res. 2001;88:609-614.
36. Naga Prasad SV, Esposito G, Mao L, Koch WJ, Rockman HA. G-βγ-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J Biol Chem. 2000;275:4693-4698.
37. Rockman HA, Chien KR, Choi DJ, Iaccarino G, Hunter JJ, Ross J Jr, Lefkowitz RJ, Koch WJ. Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A. 1998;95:7000-7005.
38. Tong H, Steenbergen C, Koch WJ, Murphy E. Gβγ-dependent signaling pathway in ischemic preconditioning: a role for endosomal signaling. Circulation. 2003;108(suppl IV):IV-37. Abstract.
39. Qin S, Chock PB. Implication of phosphatidylinositol 3-kinase membrane recruitment in hydrogen peroxide-induced activation of PI3K and Akt. Biochemistry. 2003;42:2995-3003.
40. Tohgo A. Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM. β-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem. 2002;277:9429-9436.
41. Tohgo A, Choy EW, Gesty-Palmer D, Pierce KL, Laporte S, Oakley RH, Caron MG, Lefkowitz RJ, Luttrell LM. The stability of the G protein-coupled receptor-β-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem. 2003;278:6258-6267.
42. Scheid MP, Woodgett JR. PKB/Akt: functional insights from genetic models. Nat Rev Mol Cell Biol. 2001;2:760-768.
43. Bell RM, Yellon DM. The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold: an investigation in eNOS knockout mice. Cardiovasc Res. 2001;52:274-280.
44. Ping P, Takano H, Zhang J, Tang XL, Qiu Y, Li RC, Banerjee S, Dawn B, Balafonova Z, Bolli R. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res. 1999;84:587-604.
45. Sasaki N, Sato T, Ohler A, O'Rourke B, Marbán E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation. 2000;101:439-445.
46. Pap M, Cooper GM. Role of glycogen synthase kinase-3 in the phosphatidylinositol-3-kinase/Akt cell survival pathway. J Biol Chem. 1998;273:19929-19932.
47. Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection is mediated by glycogen synthase kinase inhibition via phosphatidylinositol-3-kinase and target of rapamycin-dependent pathways. Circulation. 2003;108(suppl IV): IV-126. Abstract.
48. Murphy E, Tong H, Steenbergen C. Preconditioning: is the Akt-ion in the PI3K pathway? J Mol Cell Cardiol. 2003;35:1021-1025.
49. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res. 1994;75:586-590.
50. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res. 1997;81:404-414.
51. Dorn GW 2nd, Souroujon MC, Liron T, Chen CH, Gray MO, Zhou HZ, Csukai M, Wu G, Lorenz JN, Mochly-Rosen D. Sustained in vivo cardiac protection by a rationally designed peptide that causes ε protein kinase C translocation. Proc Natl Acad Sci U S A. 1999;96:12798-12803.
52. Chen W, Wetsel W, Steenbergen C, Murphy E. Effect of ischemic preconditioning and PKC activation on acidification during ischemia in rat heart. J Mol Cell Cardiol. 1996;28:871-880.
53. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM. Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol. 1999;31:1937-1948.
54. + production. J Mol Cell Cardiol. 2002;34:361-367.
55. Ping P, Song C, Zhang J, Guo Y, Cao X, Li RC, Wu WJ, Vondriska TM, Pass JM, Tang XL, Pierce WM, Bolli R. Formation of PKC-ε-Lck signaling modules confer cardioprotection. J Clin Invest. 2002;109:499-507.
56. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol. 1997;29:207-216.
57. Toker A, Meyer M, Reddy KK, Falck JR, Aneja R, Aneja S, Sparra A, Burns DJ, Ballas LM, Cantley LC. Activation of protein kinase C family members by the novel polyphosphoinositides Ptdlns-3,4-P2 and PtdIns-3,4,5-P3. J Biol Chem. 1994;269:32358-32367,
58. + channels by protein kinase C. Circ Res. 1998;83:110-114.
59. Chen W, Glasgow W, Murphy E, Steenbergen C. Lipoxygenase metabolism of arachidonic acid in ischemic preconditioning and PKC-induced protection in heart. Am J Physiol. 1999;276:H2094-H2101.
60. Fryer RM, Pratt PF, Hsu AK, Gross GJ. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther. 2001;296:642-649.
61. Ping P, Zhang J, Cao X, Li RC, Kong D, Tang XL, Qiu Y, Manchikalapudi S, Auchampach JA, Black RG, Bolli R. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol. 1999;276: H1468-H1481.
62. Strohm C, Barancik T, Bruhl ML, Kilian SA, Schaper W. Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium. J Cardiovasc Pharmacol. 2000;36:218-229.
63. Behrends M, Schulz R, Post H, Alexandrov A, Belosjorow S, Michel MC, Heusch G. Inconsistent relation of MAPK activation to infarct size in reduction by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol. 2000;279:H1111-H1119.
64. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, Ping P. Mitochondrial PKCε and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCε-MAPK interactions and differential MAPK activation in PKCε-induced cardioprotection. Circ Res. 2002;90:390-397.
65. ATP channels, free radicals and MEK1/2. J Mol Cell Cardiol. 2003;35:985-992.
66. Steenbergen C. The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury: relationship to ischemic preconditioning. Basic Res Cardiol. 2002;97:276-285.
67. Piomelli D, Greengard P. Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signaling. Trends Pharmacol Sci. 1990;11:367-373.
68. Murphy E, Glasgow W, Fralix T, Steenbergen C. Role of lipoxygenase metabolites in ischemic preconditioning. Circ Res. 1995;76:457-467.
69. Gabel SA, London RE, Funk CD, Steenbergen C, Murphy E. Leukocyte-type 12-lipoxygenase-deficient mice show impaired ischemic preconditioning-induced cardioprotection. Am J Physiol Heart Circ Physiol. 2001;280:H1963-H1969.
70. Patel HH, Fryer RM, Gross ER, Bundey RA, Hsu AK, Isbell M, Eusebi LO, Jensen RV, Gullans SR, Insel PA, Nithipatikom K, Gross GJ. 12-Lipoxygenase in opioid-induced delayed cardioprotection: gene array, mass spectrometric, and pharmacological analyses. Circ Res. 2003;92:676-682.
71. Bolli R, Dawn B, Xuan YT. Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc Med. 2003;13:72-79.
72. Zhang J, Ping P, Vondriska TM, Tang XL, Wang GW, Cardwell EM, Bolli R. Cardioprotection involves activation of NF-κB via PKC-dependent tyrosine and serine phosphorylation of IκB-α. Am J Physiol Heart Circ Physiol. 2003;285:H1753-H1758.
73. Weiss JN, Korge P. The cytoplasm: no longer a well-mixed bag. Circ Res. 2001;89:108-110.
74. Mochly-Rosen D. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science. 1995;268:247-251.
75. Bers DM, Ziolo M. When is cAMP not cAMP? Effects of compartmentation. Circ Res. 2001;89:373-375.
76. Arrell DK, Neverova I, Fraser H, Marbán E, Van Eyk JE. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1. Circ Res. 2001;89:480-487.
77. Deleted in proof.
78. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med. 2000;6:513-519.
79. Chen Z, Chua CC, Ho YS, Hamdy RC, Chua BH. Overexpression of bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol. 2001;280: H2313-H2320.
80. Liu Y, Sato T, O'Rourke B, Marbán E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 1998;97:2463-2469.
81. ATP channels. Am J Physiol. 1998;274:H909-H914.
82. Deleted in proof.
83. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res. 2002;55:534-543.
84. Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, Halestrap AP. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol. 2003;549:513-524.
85. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res. 2003;93:292-301.
86. Akao M, Ohler A, O'Rourke B, Marbán E. Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ Res. 2001;88:1267-1275.
87. ATP channels in ischemic cardioprotection. Circulation. 2000;101:2418-2423.
88. ATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol. 2002;542:735-741.
89. ATP channel opener diazoxide protects cardiac myocytes during metabolic inhibition without causing mitochondrial depolarization or flavoprotein oxidation. Br J Pharmacol. 2001;134:535-542.
90. ATP channels in rat mitochondria. J Physiol. 2003;547:893-902.
91. Lim KH, Javadov SA, Das M, Clarke SJ, Suleiman MS, Halestrap AP. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol. 2002;545:961-974.
92. 2+ overload in rat cardiac mitochondria. J Physiol. 1999;519:347-360.
93. 2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ Res. 2001;89:891-898.
94. ATP channels attenuates the ouabain-induced calcium overload in mitochondria. Circ Res. 2001;89:856-858.
95. Forbes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res. 2001;88:802-809.
96. ATP channels triggers the preconditioning state by generating free radicals. Circ Res. 2000;87:460-466.
97. Zhang DX, Chen YF, Campbell WB, Zou AP, Gross GJ, Li PL. Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ Res. 2001;89:1177-1183.
98. ATP channel by redox agents. Biochim Biophys Acta. 1999;1410:91-96.
99. Ozcan C, Holmuhamedov EL, Jahangir A, Terzic A. Diazoxide protects mitochondria from anoxic injury: implications for myopreservation. J Thorac Cardiovasc Surg. 2001;121:298-306.
100. + channel protects the ischemic heart. Am J Physiol Heart Circ Physiol. 2002;283:H284-H295.
101. Wunder UR, Colombini M. Patch clamping VDAC in liposomes containing whole mitochondrial membranes. J Membr Biol. 1991;123:83-91.
102. Tsujimoto Y, Shimizu S. VDAC regulation by the bcl-2 family of proteins. Cell Death Differ. 2000;7:1174-1181.
103. Imahashi K, Schneider MD, Steenbergen C, Murphy E. Transgenic expression of Bcl-2 modulates energy metabolism and prevents cytosolic acidification during ischemia and reduces ischemia-reperfusion injury. Circulation. 2003;108(suppl IV):IV-297. Abstract.
104. Chatterjee S, Stewart AS, Bish LT, Jayasankar V, Kim EM, Pirolli T, Burdick J, Woo YJ, Gardner TJ, Sweeney H. Viral gene transfer of the antiapoptotic factor Bcl-2 protects against chronic postischemic heart failure. Circulation. 2002;106:212-217.
105. Jennings RB, Reimer KA, Steenbergen C. Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia. J Mol Cell Cardiol. 1991;23:1383-1395.
106. Vuorinen K, Ylitalo K, Peuhkurinen K, Raatikainen P, Ala-Rami A, Hassinen IE. Mechanisms of ischemic preconditioning in rat myocardium: roles of adenosine, cellular energy state, and mitochondrial F1F0-ATPase. Circulation. 1995;91:2810-2818.
107. Vander Heide RS, Hill ML, Reimer KA, Jennings RB. Effect of reversible ischemia on the activity of the mitochondrial ATPase: relationship to ischemic preconditioning. J Mol Cell Cardiol. 1996;28:103-112.
108. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, Korsmeyer SJ. BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell Biochem. 2001;8:705-711.
109. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 1999;399:483-487.
110. Shimizu S, Ide T, Yanagida T, Tsujimoto Y. Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c. J Biol Chem. 2000;275:12321-12325.
111. Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem. 2002;277:7610-7618.
112. Korge P, Honda HM, Weiss JN. Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning. Proc Natl Acad Sci U S A. 2002;99:3312-3317.
113. Schwanke U, Konietzka I, Duschin A, Schulz R, Heusch G. No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol. 2002;283:H1740-H1742.
114. Jain SK, Schuessler RB, Saffitz JE. Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res. 2003;92:1138-1144.
115. Zucchi R, Ronca F, Ronca-Testoni S. Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection? Pharmacol Ther. 2001;89:47-65.
116. 19F nuclear magnetic resonance study. Circ Res. 1998;83:898-907.
117. ATP channels and actin cytoskeleton. Am J Physiol. 1999;276: H1361-H1368.
118. Wei H, L'Ecuyer T, Vander Heide RS. Effect of increased expression of cytoskeletal protein vinculin on ischemia-reperfusion injury in ventricular myocytes. Am J Physiol. 2003;284:H911-H918.
119. Armstrong SC, Shivell CL, Ganote CE. Differential translocation or phosphorylation of αB crystallin cannot be detected in ischemically preconditioned rabbit cardiomyocytes. J Mol Cell Cardiol. 2000;32:1301-1314.
120. Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol. 2001;2:67-71.